Nanoparticle-Based Therapies for Neurotropic Viral Infections: Mechanisms, Challenges, and Future Prospects.
Rev Med Virol
; 34(5): e2575, 2024 Sep.
Article
em En
| MEDLINE
| ID: mdl-39160646
ABSTRACT
Neurotropic viral infections pose a significant challenge due to their ability to target the central nervous system and cause severe neurological complications. Traditional antiviral therapies face limitations in effectively treating these infections, primarily due to the blood-brain barrier, which restricts the delivery of therapeutic agents to the central nervous system. Nanoparticle-based therapies have emerged as a promising approach to overcome these challenges. Nanoparticles offer unique properties that facilitate drug delivery across biological barriers, such as the blood-brain barrier, and can be engineered to possess antiviral activities.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Barreira Hematoencefálica
/
Viroses do Sistema Nervoso Central
/
Nanopartículas
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Rev Med Virol
Ano de publicação:
2024
Tipo de documento:
Article